| 1 |
31949019 | Low-dose Btk inhibitors selectively block platelet activation by CLEC-2. | 2021 Jan 1 |
1 |
| 2 |
30685871 | Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib. | 2019 Mar |
1 |
| 3 |
29559479 | Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans. | 2018 Jun 14 |
2 |
| 4 |
29995658 | Ibrutinib-related bleeding: pathogenesis, clinical implications and management. | 2018 Sep |
1 |
| 5 |
26359510 | Ibrutinib Inhibits Platelet Integrin αIIbβ3 Outside-In Signaling and Thrombus Stability But Not Adhesion to Collagen. | 2015 Nov |
1 |